NIH-funded research U01 cooperative agreement

Understanding how HIV and cannabis affect brain cells

Official title: Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure

Funded at Weill Medical Coll of Cornell Univ · NIH-11082984 · Data updated 2026-11-12

This study is looking at how cannabis affects the brains of people living with HIV, to see if it helps or harms brain health, and it’s designed for those interested in understanding the impact of cannabis on their cognitive well-being.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startMay 15, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$2,276,913
NIH project number5U01DA058527-03
Project IDNIH-11082984 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who use cannabis for recreational or medicinal purposes.

Less likely to help

Patients who do not have HIV or do not use cannabis may not receive any benefit from this research.

What this research studies

This research investigates the effects of cannabis on the brain's neurogenic regions in individuals living with HIV. It aims to clarify whether cannabis use is beneficial or harmful to the central nervous system by examining specific brain cell types and their responses to cannabinoids. Using advanced single-cell technologies and a nonhuman primate model, the study will analyze brain tissues to uncover the cellular and molecular changes associated with HIV and cannabis exposure. The findings could provide insights into the relationship between cannabis use and cognitive health in people living with HIV.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of cognitive health in individuals living with HIV who use cannabis.

How similar studies have gone: Previous research has shown promising results in understanding the effects of cannabinoids on brain health, but this specific approach focusing on single-cell changes in the context of HIV is relatively novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Ndhlovu, Lishomwa C — Weill Medical Coll of Cornell Univ
  • Study coordinator: Ndhlovu, Lishomwa C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.